Dow Jones Top Company Headlines at 9 AM ET: Uber Revenue Jumps on Increased Trips, Users | RTX ...

Dow Jones
Feb 04

Uber Revenue Jumps on Increased Trips, Users

Uber Technologies logged a jump in fourth-quarter revenue, boosted by higher trip volumes and active users, though profit fell on a large charge tied to the company's equity investments.

----

RTX to Increase Missile Production Under Pentagon Deals

RTX's Raytheon division committed to surging its missile output, following pressure from both Pentagon officials and President Trump to increase production.

----

Eli Lilly Profit Rises Amid Weight-Loss Drug Demand

Eli Lilly reported higher fourth-quarter profit on the back of surging demand for its GLP-1 weight-loss drugs.

----

Texas Instruments to Acquire Silicon Labs in Deal Valued at $7.5 Billion

Texas Instruments agreed to acquire Silicon Labs in a deal with an enterprise value of about $7.5 billion, including cash and debt.

----

Fox Revenue Climbs on Growth in Cable, Advertising

Fox recorded higher revenue in the fiscal second quarter as growth in the cable segment and higher advertising revenue offset a slight decline in the television segment.

----

Wegovy Maker Novo Nordisk's Shares Slump After Guidance Disappoints

The stock tumbled 19% at the opening bell in Copenhagen after its outlook for the year ahead disappointed investors.

----

GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

GE HealthCare Technologies said profit fell in the fourth quarter, despite higher revenue, as the company continues to operate in what Chief Executive Peter Arduini called a dynamic macroeconomic environment.

----

Yum Brands Logs Higher Revenue on Growth at Taco Bell, KFC

Yum Brands logged higher revenue in its latest quarter, helped by growth at its Taco Bell and KFC businesses.

----

New York Times Profit Rises on Bundle Subscription Growth

Total subscription revenues rose 9.4% as an increase in bundle and non-news single-product subscription revenue helped offset a decline in news-only subscription revenues.

----

Brookfield Asset Management Names Connor Teskey CEO

Brookfield Asset Management named Connor Teskey as successor to long-serving Chief Executive Bruce Flatt, who will remain chairman as well as CEO of parent Brookfield.

----

AbbVie Revenue Rises on Immunology Growth

AbbVie posted higher fourth-quarter revenue on the back of growth from its immunology portfolio, led by arthritis and Crohn's disease drugs Skyrizi and Rinvoq.

----

Equifax Revenue Rises Despite Weak Hiring, Mortgage Markets

Equifax reported higher fourth-quarter revenue as its mortgage and workforce solutions businesses shrugged off weakness in the broader housing and hiring markets.

----

UBS Shares Fall After Money Outflows Hit U.S. Wealth-Management Business

The unit brought in $8.5 billion in net new assets last quarter, a sharp drop compared with $38 billion in the previous quarter.

----

Zurich Insurance Reaches $11 Billion Deal to Buy U.K. Insurer Beazley

The Swiss insurer has been courting Beazley since last year and in January went public with several offers that were turned down.

----

Spain's Santander Launches Buyback Alongside Earnings Beat

The lender reported a 15% rise in net profit for the last quarter of 2025 and approved a €5 billion share-buyback program.

----

KKR Makes AI Play With Nearly $11 Billion Asia Data-Center Deal

The U.S. firm will hold a 75% stake in the data-center operator, with Singtel owning the remainder.

----

Infineon Raises Investments to Meet Unrelenting AI Chip Demand

Funds are set to go toward a facility in Dresden, as well as other sites, to expand the manufacturing of semiconductors powering data centers and other AI infrastructure.

----

Novartis Forecasts Profitability Hit From Generic Drug Competition in U.S.

The pharma major said it faces the largest drug-patent expiry headwind in its history this year.

 

(END) Dow Jones Newswires

February 04, 2026 09:00 ET (14:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10